Centre for Industry Education Collaboration

GAMBLING AFFILIATES CREATE NEW GROUP TO PROTECT CONSUMERS: RESPONSIBLE GAMBLING AFFILIATE ASSOCIATION ("RGAA" or the "Group" or the "Association")

Retrieved on: 
Wednesday, November 8, 2023
Consumer protection, Conduct, Heart, Gambling, Choice, Human, Centre for Industry Education Collaboration, Advertising, Environment, Business, Social responsibility, Catena Media, Marketing, Ecosystem, Education, Responsibility, Longevity, Empowerment

NEW YORK, Nov. 8, 2023 /PRNewswire/ -- Today, we are proud to announce the formation of the RESPONSIBLE GAMBLING AFFILIATE ASSOCIATION, a coalition of like-minded companies dedicated to nurturing an environment where gambling affiliate companies can serve the commercial needs of the regulated online gambling market.

Key Points: 
  • The Responsible Gambling Affiliate Association (RGAA), founded by the six major US gambling affiliates, will serve as a trade association to advocate for reasonable regulation, responsible advertising, and consumer protection.
  • The RGAA's mission is to champion responsible gambling marketing and advertising practices, empower gambling affiliate companies to influence sensible regulation, and protect consumer interests, while effectively participating in the market.
  • Comprising six major players in the US online gambling affiliate sector, the Association includes Better Collective, Catena Media, Gambling.com Group, oddschecker Global Media, Spotlight Sports Group, and XLMedia plc.
  • Although gambling affiliates are subject to significant regulation, there is potential for further improvement in elevating the standards of the affiliate marketing sector.

Ultima Genomics to Present at ASHG and Provide Updated Reference Data Set

Retrieved on: 
Tuesday, October 31, 2023
Health, Genetics, Health Technology, Research, Science, Biotechnology, ASHG, Whole genome sequencing, Genomics, Stanford University, Booth, Genetic disorder, Alternative splicing, Centre for Industry Education Collaboration, UG, Society, Baylor College of Medicine, Fusion, ATAC, American Society of Human Genetics, Human genetics, Baylor, Scale, Ultima, Chemistry, Gene expression, Baylor University, Antibiotics, Music, Fine chemical, Communications satellite

Watchmaker Genomics will demonstrate gene fusion detection via cost-effective whole transcriptome sequencing using the optimized Watchmaker RNA Library prep kit.

Key Points: 
  • Watchmaker Genomics will demonstrate gene fusion detection via cost-effective whole transcriptome sequencing using the optimized Watchmaker RNA Library prep kit.
  • In conjunction with the conference, Ultima will be releasing a new data set demonstrating significant improvements to the technology made through early access.
  • In particular, the data demonstrates significant improvements in indel accuracy made through a variety of advancements across chemistry and bioinformatics.
  • Industry Education Session: Empowering Genomics at Scale Thursday, Nov. 2 | Room 140AB | Talks 3:30 - 4:30 p.m.

IDWeek 2023: Shionogi and Qpex Biopharma, Inc. Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease

Retrieved on: 
Thursday, September 7, 2023
Health, Infectious Diseases, COVID-19, Research, Science, Pharmaceutical, Biotechnology, Abstract, Inc., Doctor of Pharmacy, Senior, SARS-CoV-2, Infection, Safety, Hospital, Head, Achromobacter, Stenotrophomonas maltophilia, Part, Non, Pseudomonas aeruginosa, Acquisition, Centre for Industry Education Collaboration, DTR, Learning, Effectiveness, Site, Patient, Sense, Randomized controlled trial, Generic, SENTRY, Treatment, Interim analysis, Pharmaceutical industry, Shionogi, Ensitrelvir

: S-217622, hereafter “ensitrelvir”), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcroja® in Europe.

Key Points: 
  • : S-217622, hereafter “ensitrelvir”), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcroja® in Europe.
  • Shionogi recently extended its infectious disease innovation platform with the acquisition of Qpex Biopharma Inc. (Qpex) in July.
  • The acquisition brings a novel investigational ß-lactamase inhibitor to Shionogi, expanding the company’s pipeline of critically needed antimicrobials, and further augmenting its R&D capabilities and expertise.
  • During IDWeek, Shionogi will host a Learning Lounge with David Nicolau, PharmD, titled Fetroja® (cefiderocol), An Overview of In Vitro and Clinical Data on Friday, October 13, from 10:15 – 11:00 AM ET.

SorensenGross Construction Receives Michigan Top Workplaces Award

Retrieved on: 
Thursday, November 24, 2022
Centre for Industry Education Collaboration, Environment, Communication, Workplace, Detroit Free Press Building, Multi, Commercial, Free, Internationalization and localization, Detroit Free Press, Hospital, Water, Family, Airport, Management, Construction

FLINT, Mich., Nov. 23, 2022 /PRNewswire-PRWeb/ -- SorensenGross has been awarded a Top Workplaces 2022 honor by The Detroit Free Press Top Workplaces. The list is based solely on employee feedback gathered via a third-party survey administered by employee engagement technology partner Energage, LLC. The confidential survey uniquely measures 15 culture drivers that are critical to the success of any organization, including alignment, execution, and connection, just to name a few.

Key Points: 
  • Detroit Free Press Names Sorensen Gross Construction Services a winner of the Michigan Top Workplaces 2022 Award.
  • FLINT, Mich., Nov. 23, 2022 /PRNewswire-PRWeb/ -- SorensenGross has been awarded a Top Workplaces 2022 honor by The Detroit Free Press Top Workplaces.
  • The list is based solely on employee feedback gathered via a third-party survey administered by employee engagement technology partner Energage, LLC.
  • As a recognized provider of quality construction management and personnel services, SorensenGross has a long history of supporting and developing its staff.

TAE Life Sciences to Sponsor Industry Theater Session on the Future of Precision Oncology at 2022 ASTRO Annual Meeting

Retrieved on: 
Tuesday, October 18, 2022
Research, Technology, Other Technology, Clinical Trials, Biotechnology, Radiology, Pharmaceutical, Health, Science, Oncology, Neutron, News, Radiation, Neutron capture therapy of cancer, Sale, Therapy, American Society for Radiation Oncology, Neoplasm, Society, Patient, Industry, Senior, Technology, Cancer, Centre for Industry Education Collaboration, TLS, Radiation therapy, ASTRO, Protein Sciences, Economics, Health, Research, Boron, BNCT, Pharmaceutical industry, Medical imaging

TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced the sponsorship of an Industry Education session focused on the future of biologically targeted radiotherapy at the American Society for Radiation Oncology (ASTRO) Annual Meeting, occurring October 22-26, 2022.

Key Points: 
  • TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced the sponsorship of an Industry Education session focused on the future of biologically targeted radiotherapy at the American Society for Radiation Oncology (ASTRO) Annual Meeting, occurring October 22-26, 2022.
  • The Industry Theater session, A Glimpse into the Future: Biologically Targeted Radiotherapy will feature presentations by Sunil Krishnan, M.B.B.S., M.D., Professor, Radiation Oncology, UT Health Houston, Minesh P. Mehta, MD., Deputy Director & Chief of Radiation Oncology, Miami Cancer Institute and Art Raitano, Senior Director Protein Sciences, TAE Life Sciences.
  • Session Title: A Glimpse into the Future: Biologically Targeted Radiotherapy
    BNCT is one of the most exciting developments in radiation therapy, and yet it remains inadequately explored in the clinic due to technological and pharmacological limitations.
  • TAE Life Sciences (TLS) is a privately held biotechnology company committed to developing a new biologically targeted radiation therapy based on Boron Neutron Capture Therapy (BNCT).

Wildnote CEO Kristen Hazard Receives 2021 EBJ Business Achievement Award

Retrieved on: 
Monday, February 28, 2022
Public policy, GLOBE, Enterprise, Software as a service, Compliance, Natural Resources, Digitization, Environment, CA, EBI, EBJ, Consultant, SLO, Biomonitoring, Hyco International Inc, SAN, Technology, CEO, Research, Green Zone Community Climate Action, Time, Renewable energy, Centre for Industry Education Collaboration

SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Environmental Business Journal (EBJ), a business research publication that provides high-value strategic business intelligence to the environmental industry, has honored Kristen Hazard, Wildnote CEO, with a Business Achievement Award for Industry Leadership in 2021.

Key Points: 
  • SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Environmental Business Journal (EBJ), a business research publication that provides high-value strategic business intelligence to the environmental industry, has honored Kristen Hazard, Wildnote CEO, with a Business Achievement Award for Industry Leadership in 2021.
  • Hazard, founder and CEO of Wildnote (San Luis Obispo, Calif.) and developer of the company's groundbreaking environmental compliance reporting software, was selected for her contributions to Industry Education, Public Policy Dialog, and Community Climate and Energy Action.
  • Throughout 2021, Kristen hosted free monthly webinars engaging industry experts with a wide audience to share best practices for integrating technology into environmental consulting activities.
  • *The Wildnote mission is to help protect natural resources by automating the process of environmental compliance.

NanoString Unveils Spatial Organ Atlas During the American Society of Human Genetics (ASHG) Conference

Retrieved on: 
Monday, October 18, 2021
Software, Research, Other Health, Oncology, Technology, Medical Devices, Genetics, Science, Nanotechnology, Biotechnology, Other Technology, Health, Other Science, Solution, Time, MicroRNA, Brain, Conference, Disease, Transcriptome, Nature Communications, Colon, Lymph, Data, Research, Kidney, SMI, Architecture, Tissue, Centre for Industry Education Collaboration, RNA, Health, Weill Cornell Medicine, Günther Pancke, NanoString Technologies, Alpha, Technology, Endothelium, Doctor of Philosophy, Department, Epithelium, Multimedia, Pancreas, Biology, Poster, Department of Medicine – University of Pamplona, NASDAQ, COVID-19, DSP, Mount Sinai, Cancer, Gene, Icahn School of Medicine at Mount Sinai, Biophysics, Protein, Micro-Imaging Dust Analysis System, Spatial organization, Physiology, WTA, Medical imaging, Microscope, Interior design

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    "The Spatial Organ Atlas maps the whole transcriptomes of the multi-cellular molecular machines that drive organ biology," said Joseph Beechem, Ph.D., chief scientific officer, NanoString.
  • The Spatial Organ Atlas can be explored on NanoString's website, http://www.nanostring.com/spatial-organ-atlas , through downloadable datasets, including images, sequencing data, and analysis results.
  • Dr. Beechem will provide details of the Spatial Organ Atlas initiative and highlight the latest technological advancements at NanoString.
  • NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.